{
    "organizations": [],
    "uuid": "a1c5f3228daafef53c5e40241910752cb966e7d9",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-shanghai-hile-bio-technology-to-bu/brief-shanghai-hile-bio-technology-to-buy-medical-firm-via-cash-share-issue-idUSH9N1QH02E",
    "ord_in_thread": 0,
    "title": "BRIEF-Shanghai Hile Bio-Technology To Buy Medical Firm Via Cash, Share Issue",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 4 (Reuters) - Shanghai Hile Bio-Technology Co Ltd :\n* SAYS IT PLANS TO BUY MEDICAL FIRM SHANGHAI JIEMEN VIA CASH, SHARE ISSUE\n* SAYS SHARE TRADE REMAINS SUSPENDED Source text in Chinese: bit.ly/2FfvjR2 Further company coverage: (Reporting by Hong Kong newsroom)\n ",
    "published": "2018-03-04T20:24:00.000+02:00",
    "crawled": "2018-03-05T13:12:48.003+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "shanghai",
        "hile",
        "co",
        "ltd",
        "say",
        "plan",
        "buy",
        "medical",
        "firm",
        "shanghai",
        "jiemen",
        "via",
        "cash",
        "share",
        "issue",
        "say",
        "share",
        "trade",
        "remains",
        "suspended",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "reporting",
        "hong",
        "kong",
        "newsroom"
    ]
}